[Held on September 9th!14th Economic Security Study Group] "Economic Security in the Health and Medical Field" -Introduction of Supply Chain Analysis Cases of Pharmaceutical Companies Utilizing FRONTEO AI
The novel coronavirus has had a major impact on the world.
While countries are competing fiercely to secure strategic goods and acquire important technologies, vaccines and therapeutic drugs are the core of the "strategic goods" that countries around the world have been fighting over.
Active pharmaceutical ingredients (APIs) are mainly manufactured in China and India, and we rely on China for many raw materials.
Important technologies and items in the health crisis area change dynamically even in the middle of the crisis, depending on the content of the threat, supply and demand in the market, and the degree of dependence on a specific country. and armed attack situations pose a national crisis.
In order to protect the lives and health of the people, we will explain how to prepare and respond to economic security in the "health crisis" area.
◆ Theme: "Economic security in the health and medical field" -Introduction of supply chain analysis cases of pharmaceutical companies using FRONTEO AI
◆ Date: September 2022, 9 (Wednesday) 14: 15-00: 16
◆ Webinar type: Zoom Webinar
◆ Participation conditions: For companies
Participants from the same industry, individuals, and free e-mail addresses are not allowed to participate.
International House of Japan
Senior Research Fellow, Asia Pacific Initiative (API) and Senior Research Fellow, Institute of Geoeconomics (IOG)
Yoshiyuki Sagara
Authors include "Corona Response in Japan as Crisis Management", "Asteion" No. 94 (May 2021), "New Corona Response/Private Extraordinary Investigation Committee (Corona Private Inquiry) Investigation and Verification Report" (co-author, 5) October 2020), etc. He served as the secretariat for the "Corona Private Inquiry," which examined Japan's response to the coronavirus in the first half of 10, and co-authored the chapters on border control, border measures, the official residence, and therapeutic drugs and vaccines in the investigation and verification report.The Corona private investigation report will also be published in English in 2020.
Mari Yamamoto
Participated in FRONTEO in 2018, became a director in 2020, and is in charge of and directs the president's office and the entire AI solution business.
In the life science AI business, we promoted the development of diagnostic support, disease prediction, and drug discovery support AI systems using the artificial intelligence engine "Concept Encoder", and directed the launch of the world's first medical device using language analysis AI.Take on the challenge of new areas in life science.
In the business intelligence business, we utilize the artificial intelligence engine "KIBIT" to support corporate DX promotion.In the field of economic security as well, we are advocating a change in consciousness together with experts and researchers, and developing intelligence-based solutions for governments, government agencies, and companies.Help companies make strategic decisions with a fact-based approach.
As a top company in the field of natural language analysis, he plans and directs the growth strategy of the AI solution business.
Articles in the same category
Exploring patient stratification biomarkers for IgA nephropathy using AI: Overcoming bias with AI
Parkinson's disease - Analyzing drug discovery targets using paper search AI
Economic Security Symposium co-hosted by FRONTEO x Moody's Analytics Japan on April 4th
Searching for new targets for sporadic ALS using AI: Become friends with AI
[Webinar held on 3/25] Risk of important information leakage of Japanese companies due to cross-border application of discovery and its response
[On-site seminar held on 3/19] Latest trends in AI and competition law - from a global perspective <Simultaneous interpretation and reception available>
[Webinar held on 3/5] Are you fully prepared for a series of information leaks?: Recommendation of mock training from a crisis management perspective
[3/13 31st Economic Security Study Session] Strategic importance of “India” towards the post-China era
[Webinar held on 3/12] Learning from court precedents: “Initial response and legal measures in cases of trade secrets taken out by retired employees”